Thromboprophylaxis

Articles on this topic

Dosing of Enoxaparin in Morbidly Obese Patients

How to optimally dose enoxaparin in morbidly obese patients? This question was addressed by a…

11. 11. 2021 Source: Thromboprophylaxis

Mladý mužský pacient na návštěvě ženského lékaře traumatologa

Clinical Characteristics of Trauma Patients Requiring Dosing Adjustments of Enoxaparin in TEN Prevention

Injuries and trauma surgical procedures represent a significant risk factor for the…

4. 11. 2021 Source: Thromboprophylaxis

Echokardiografie_srdce_monitoring_kardiomyopatie_angina_pectoris_septum_venózní_hypertenze

Efficacy and Safety of Enoxaparin as Bridging Anticoagulant Therapy After Ventricular Assist Device Implantation

The implantation of a ventricular assist device has become an increasingly common method in…

1. 10. 2021 Source: Thromboprophylaxis

Administration of Low-Molecular-Weight Heparin After Hemorrhagic Stroke: What Is the Appropriate Timing?

Hemorrhagic stroke (HS) is a condition that raises doubts and concerns about anticoagulation.…

30. 9. 2021 Source: Thromboprophylaxis

Silueta_lékaře_infuze_nemocniční_koridor_chodba_nemocnice

Thromboprophylaxis as a Common Part of Care for At-Risk Patients Requiring Hospitalization: Yes or No?

The proportion of patients requiring hospitalization who are at high risk of developing…

28. 5. 2021 Source: Thromboprophylaxis

Thromboprophylaxis in Generalized Pancreatic Cancer

Pancreatic adenocarcinoma is one of the tumors with the highest risk of developing…

28. 5. 2021 Source: Thromboprophylaxis

medicina_zena_zily_tromboza_nohy_doktor_vysetreni

Extended Thromboprophylaxis with Enoxaparin After Bariatric Surgery

A recent retrospective study involving 312 patients after bariatric surgery indicated that…

29. 4. 2021 Source: Thromboprophylaxis

seniorka_v_nemocnicni_posteli_luzko_stari_geriatrie

Perioperative Thromboprophylaxis in Elderly Patients

Thromboembolic disease (TED) is among the most common causes of death in hospitalized patients…

29. 4. 2021 Source: Thromboprophylaxis

Thromboprophylaxis with Enoxaparin Reduces Mortality in Patients Hospitalized with COVID-19

Severe acute respiratory syndrome caused by COVID-19 is associated with a hypercoagulable…

11. 3. 2021 Source: Thromboprophylaxis

How to Prevent and Treat Thromboembolic Disease in Cancer Patients

Malignancy is one of the risk factors for the development of thromboembolic disease (TED).…

6. 3. 2021 Source: Thromboprophylaxis

Different doses of LMWH in hospitalized patients with COVID-19 –⁠ interim experience

Many experts recommend administering heparin to patients with COVID-19 as part of…

18. 11. 2020 Source: Thromboprophylaxis

Enoxaparin in Weight-Based Dosing for Thromboprophylaxis in Hospitalized Cancer Patients

Cancer patients are at higher risk of developing thromboembolic disease during…

6. 11. 2020 Source: Thromboprophylaxis

Mass in the Left Atrium Appendage -⁠ Case Report

A symptomatic mass in the left atrial appendage warrants thorough investigation and radical…

14. 9. 2020 Source: Thromboprophylaxis

vysledky_lekar_cte_studie_zavery_analyza_2

Comparison of the Efficacy and Safety of Two Enoxaparin Dosing Regimens in Patients After Chest Surgery

Effective prevention of thromboembolic disease in patients undergoing chest surgery is one of…

31. 8. 2020 Source: Thromboprophylaxis

Thromboprophylaxis in Cancer Patients −⁠ Results of Current Meta-Analysis

A recently published meta-analysis shows the benefits of thromboprophylaxis in cancer…

27. 5. 2020 Source: Thromboprophylaxis

1 2 3

E-courses on this topic

Authors: Prof. MUDr. Jan Kvasnička, DrSc.

Course detail